- Nachrichtendetail
-
24.06.2024 08:07:05 - dpa-AFX: *GSK: EMA ACCEPTS JEMPERLI+ CHEMOTHERAPY APPLICATION FOR REVIEW TO EXPAND USE FOR PATIENTS WITH ENDOMETRIAL CANCER
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
GSK PLC LS-,3125 | A3DMB5 | Xetra | 18,005 | 01.07.24 17:35:46 | -0,065 | -0,36% | 0,000 | 0,000 | 17,905 | 18,070 |
